Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cannabinoid-based MDI rescue inhaler
- Development stage
- Preclinical
- Lead developer
- Cannabis Science
- Administration
- Inhalation
01
Overview
The cannabinoid-based MDI (Metered-Dose Inhaler) rescue inhaler is a device designed to deliver precise doses of cannabinoids through oral inhalation. It provides a standardized method for administering medical cannabis with reproducible dosing manufactured according to pharmaceutical standards. The inhaler delivers low and precise doses of delta-9-tetrahydrocannabinol (THC), cannabidiol (CBD), and other cannabinoids, offering rapid onset of action and dose-dependent treatment effects. The device is intended to prevent or treat asthma/COPD attacks and may be used for pain management. Benefits include potential for lower doses, fewer adverse events, avoidance of hazardous combustion products, portability, enhanced safety, and reduced potential for overconsumption, misuse, or diversion.
- Brand names
- CBIS MDI Rescue Inhaler
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on cannabinoid-based MDI rescue inhaler.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cannabinoid-based MDI rescue inhaler.